These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8105138)

  • 1. [Review of glaucoma research].
    Pfeiffer N
    Klin Monbl Augenheilkd; 1993 Jul; 203(1):1-9. PubMed ID: 8105138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optic disc and visual field changes after trabeculectomy.
    Kotecha A; Spratt A; Bunce C; Garway-Heath DF; Khaw PT; Viswanathan A;
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4693-9. PubMed ID: 19474409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute morphologic changes that occur at the optic nerve head induced by medical reduction of intraocular pressure.
    Meredith SP; Swift L; Eke T; Broadway DC
    J Glaucoma; 2007 Sep; 16(6):556-61. PubMed ID: 17873718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin D; Smythe B; Mundorf T; Lehmann RP
    Trans Am Ophthalmol Soc; 1995; 93():421-38; discussion 439-41. PubMed ID: 8719690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early intraocular pressure response to laser trabeculoplasty 180 degrees without apraclonidine versus 360 degrees with apraclonidine.
    Allf BE; Shields MB
    Ophthalmic Surg; 1991 Sep; 22(9):539-42. PubMed ID: 1682861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M; Yücel I; Akar Y
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular pressure measurements throughout the 24 h.
    Bagga H; Liu JH; Weinreb RN
    Curr Opin Ophthalmol; 2009 Mar; 20(2):79-83. PubMed ID: 19240539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Chevrier RL; Assalian A; Duperré J; Lesk MR
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
    Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA
    Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neodymium:yttrium-aluminum-garnet capsulotomy and intraocular pressure in pseudophakic patients with glaucoma.
    Barnes EA; Murdoch IE; Subramaniam S; Cahill A; Kehoe B; Behrend M
    Ophthalmology; 2004 Jul; 111(7):1393-7. PubMed ID: 15234143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure.
    Belyea DA; Dan JA; Lieberman MF; Stamper RL
    J Glaucoma; 1997 Apr; 6(2):90-8. PubMed ID: 9098816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in the drug treatment of glaucoma.
    Hurvitz LM; Kaufman PL; Robin AL; Weinreb RN; Crawford K; Shaw B
    Drugs; 1991 Apr; 41(4):514-32. PubMed ID: 1711957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New developments in drug therapy of glaucoma].
    Pfeiffer N
    Ophthalmologe; 1992 Feb; 89(1):W1-13. PubMed ID: 1349844
    [No Abstract]   [Full Text] [Related]  

  • 15. [Encapsulated filtering blebs--incidence and methods of treatment].
    Ignjatović Z; Misailović K; Kuljaca Z
    Srp Arh Celok Lek; 2001; 129(11-12):296-9. PubMed ID: 11928614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of argon laser trabeculoplasty: is a day-one postoperative IOP check necessary?
    Mittra RA; Allingham RR; Shields MB
    Ophthalmic Surg Lasers; 1995; 26(5):410-3. PubMed ID: 8963854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molteno implant and refractory glaucoma. Evaluation of postoperative IOP control and complications with a modified surgical procedure].
    Hamard P; Loison-Dayma K; Kopel J; Hamard H; Baudouin C
    J Fr Ophtalmol; 2003 Jan; 26(1):15-23. PubMed ID: 12610405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of apraclonidine to prevent delayed IOP elevation after Nd:YAG laser posterior capsulotomy.
    Nesher R; Kolker AE
    Trans Am Ophthalmol Soc; 1990; 88():229-32; discussion 233-6. PubMed ID: 1982748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%.
    Barnes SD; Campagna JA; Dirks MS; Doe EA
    Ophthalmology; 1999 Oct; 106(10):2033-7. PubMed ID: 10519604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of laser trabeculoplasty on nocturnal intraocular pressure in medically treated glaucoma patients.
    Lee AC; Mosaed S; Weinreb RN; Kripke DF; Liu JH
    Ophthalmology; 2007 Apr; 114(4):666-70. PubMed ID: 17188360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.